Female Lung Cancer: Re-Analysis of National Survey of Lung Cancer in Korea, 2005.
- Author:
Tae Won JANG
1
;
Young Chul KIM
;
Yong Soo KWON
;
In Jae OH
;
Kyu Sik KIM
;
Sun Young KIM
;
Jeong Seon RYU
;
Ho Kee YUM
;
Kwan Ho LEE
;
Suk Joong YONG
;
Chang Geol LEE
;
Sang Yeub LEE
;
Sung Yong LEE
;
Eun Taik JEONG
;
Kwang Ho IN
;
Maan Hong JUNG
Author Information
- Publication Type:Original Article
- Keywords: Lung neoplasms; Female; Smoking; Republic of Korea
- MeSH: Adenocarcinoma; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Humans; Korea; Lung; Lung Neoplasms; Male; Prognosis; Republic of Korea; Smoke; Smoking; Survival Rate
- From:Journal of Lung Cancer 2010;9(2):57-63
- CountryRepublic of Korea
- Language:Korean
- Abstract: PURPOSE: Female lung cancers have different clinical features and therapeutic results as compared to those of male lung cancers. The aim of this study was to analyze the differences of Korean men and women with lung cancer. MATERIALS AND METHODS: We re-analyzed the results of a national survey of lung cancer conducted by the Korean Association for the Study of Lung Cancer in 2005. RESULTS: Of the 8,788 patients, 2,124 (24.2%) were female. The mean age at the diagnosis was 62.5 years for the females and 64.8 years for the males and the difference was significant (p<0.001). An age <50 years was more frequent for the women than for the men (16.2% vs. 7.9%, respectively; p=0.001). The stages between genders were different for the patients with non-small cell carcinoma (NSCLC) (p<0.001), but not for the patients with small cell carcinoma. The overall survival time was longer for woman than that for the man (p<0.001). However, the male patients had longer survival for the smokers with adenocarcinoma and the smokers with squamous cell carcinoma. The never smoker female patients had a better survival time than did the smoking female patients, but the male patient' survival was not influenced by the smoking status. The stage-specific survival rates were better for the women at all stages of NSCLC (p<0.001). The women who received chemotherapy had a longer survival time did the men who received chemotherapy (p<0.001). CONCLUSION: Women with lung cancer were relatively overrepresented among the younger patients and they smoked less intensively, raising the question of gender- specific differences in the carcinogenesis of lung cancer. Over-representation of adenocarcinoma was observed in the women regardless of their smoking status. Women with lung cancer had a better prognosis than men; however, the smoking females showed the worst prognosis. Gender and the smoking status are clearly important factors in the therapeutic approach to lung cancer.
